Literature DB >> 15580057

Helicobacter pylori and hepatitis A virus infections and the cardiovascular risk profile in patients with diabetes mellitus: results of a population-based study.

Mercy Ongey1, Hermann Brenner, Wolfgang Thefeld, Dietrich Rothenbacher.   

Abstract

OBJECTIVE: The objective of this study was to investigate the associations of sero-positivity for Helicobacter pylori (HP) and hepatitis A virus infection (HAV) with prevalence of cardiovascular diseases (CVD) and CVD-risk markers in a large population-based sample of patients with diabetes mellitus (DM), who are at high risk of developing CVD.
BACKGROUND: Several studies have suggested that chronic infections are associated with the development of atherosclerosis and coronary heart diseases (CHD).
METHODS: This analysis is based on the German National Health Interview and Examination Survey which was conducted in 1998. We identified all subjects with prevalent DM aged 40-79 years. Helicobacter pylori and HAV status were measured by serum immunoglobulin G antibodies. Prevalence of several CVD events (myocardial infarction, stroke and CHD) was recorded. In addition, serum levels of total triglycerides, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol and lipoprotein (a) were measured.
RESULTS: Among the 4285 participants of the German Health Survey aged 40-79 years, we identified 365 patients with DM. Of these, 32.1% had at least one CVD and there was a clear increase of CVD with age. Sero-prevalence of HP or HAV and their combination was not associated with the prevalence of CVD nor with mean levels of blood lipids after multivariate adjustment for covariates.
CONCLUSION: In this large group of 365 patients with diabetes mellitus no association of HP and HAV sero-prevalence with presence of CVDs or the level of serum lipids was established. Therefore it seems unlikely that HP and HAV sero-prevalence strongly influence CVD progression in patients with diabetes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15580057     DOI: 10.1097/01.hjr.0000140713.79273.07

Source DB:  PubMed          Journal:  Eur J Cardiovasc Prev Rehabil        ISSN: 1741-8267


  4 in total

1.  Helicobacter pylori infection and the risk of acute coronary syndrome: a nationwide retrospective cohort study.

Authors:  C-Y Lai; T-Y Yang; C-L Lin; C-H Kao
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-07-26       Impact factor: 3.267

Review 2.  Infectious and coronary artery disease.

Authors:  Mohammad Saeid Rezaee-Zavareh; Mohammad Tohidi; Amin Sabouri; Mahdi Ramezani-Binabaj; Mohsen Sadeghi-Ghahrodi; Behzad Einollahi
Journal:  ARYA Atheroscler       Date:  2016-01

3.  Differences in glycated hemoglobin levels and cholesterol levels in individuals with diabetes according to Helicobacter pylori infection.

Authors:  Saeda Haj; Gabriel Chodick; Sophy Goren; Wasef Na'amnih; Varda Shalev; Khitam Muhsen
Journal:  Sci Rep       Date:  2021-04-19       Impact factor: 4.379

4.  The effect of the treatment of Helicobacter pylori infection on the glycemic control in type 2 diabetes mellitus.

Authors:  Homayon Zojaji; Elnaz Ataei; Somayeh Jahani Sherafat; Mehdi Ghobakhlou; Seyed Reza Fatemi
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2013
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.